Investor Presentation • Apr 18, 2024
Investor Presentation
Open in ViewerOpens in native device viewer

Q1 2024 Operational Update
April 18, 2024

THIS DOCUMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, ITS TERRITORIES, DEPENDENCIES OR POSSESSIONS, INCLUDING ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA, OR AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR TO ANY RESIDENT THEREOF, OR ANY JURISDICTION WHERE SUCH DISTRIBUTION IS UNLAWFUL. THIS DOCUMENT IS NOT AN OFFER OR AN INVITATION TO BUY OR SELL SECURITIES IN ANY JURISDICTION.
This presentation (the "Company Presentation") has been prepared by Atlantic Sapphire ASA (the "Company"). In this Company Presentation, references to the "Company", the "Group", "we", "our", "us", or similar terms refer to the Company and its consolidated subsidiaries, except where context otherwise requires.
This Company Presentation has been prepared for information purposes only, and does not constitute or form part of, and should not be construed as, any offer, invitation or recommendation to purchase, sell or subscribe for any securities in any jurisdiction and neither the Company Presentation nor anything contained herein shall form the basis of, or be relied upon in connection with, or act as an inducement to enter into, any investment activity. This Company Presentation does not purport to contain all of the information that may be required to evaluate any investment in the Company or any of its securities and should not be relied upon to form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever. This Company Presentation is intended to present background information on the Company, its business and the industry in which it operates and is not intended to provide complete disclosure upon which an investment decision could be made.
This Company Presentation is furnished by the Company, and it is expressly noted that no representation or warranty, express or implied, as to the accuracy or completeness of any information included herein is given by the Company. This Company Presentation and the information contained herein have not been independently verified he contents of this Company Presentation are not to be construed as financial, legal, business, investment, tax or other professional advice. Each recipient should consult with its own professional advisors for any such matter and advice. Generally, any investment in the Company should be considered as a high-risk investment. A recipient of this Company Presentation acknowledges and accepts that no external advisor (neither financial or legal) has been engaged to carry out a due diligence or to verify the information contained herein.
Information provided on the market environment, developments, trends and on the competitive situation is based on data and reports prepared by third parties and/or the Company based on its own information and information derived from such third-party sources. Third party industry publications, studies and surveys generally state that the data contained therein have been obtained from sources believed to be reliable, but that there is no guarantee of the accuracy or completeness of such data.

This Company Presentation is current as of 18 April 2024. Neither the delivery of this Company Presentation nor any further discussions of the Company with any of the recipients shall, under any circumstances, create any implication that there has been no change in the affairs of the Company since such date. This Company Presentation contains several forward-looking statements relating to the business, future financial performance and results of the Company and/or the industry in which it operates. In particular, this Company Presentation contains forward-looking statements such as with respect to the Company's potential future revenues and cash flows, the Company's equity and debt financing requirements and its ability to obtain financing in a timely manner and at favourable terms. Forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words "believes", "expects", "predicts", "intends", "projects", "plans", "estimates", "aims", "foresees", "anticipates", "targets", and similar expressions. The forward-looking statements contained in this Company Presentation, including assumptions, opinions and views of the Company or cited from third party sources, are solely opinions and forecasts which are subject to risks, uncertainties and other factors that may cause actual events to differ materially from any anticipated development. All forward–looking statements attributable to the Company or persons acting on its behalf apply only as of the date of this Company Presentation and are expressly qualified in their entirety by the cautionary statements included elsewhere in this document.
The distribution of this Company Presentation by the Company in certain jurisdictions is restricted by law. Accordingly, this Company Presentation may not be distributed or published in any jurisdiction except under circumstances that will result in compliance with any applicable laws and regulations. This Company Presentation does not constitute an offer of, or an invitation to purchase, any securities.
IN RELATION TO THE UNITED STATES AND U.S. PERSONS, THIS COMPANY PRESENTATION IS BEING FURNISHED ONLY TO INVESTORS THAT ARE "QUALIFIED INSTITUTIONAL BUYERS" ("QIBs"), AS DEFINED IN RULE 144A UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "U.S. SECURITIES ACT"). THIS PRESENTATION DOES NOT CONTAIN OR CONSTITUTE AN OFFER OF, OR THE SOLICITATION OF AN OFFER TO BUY OR SUBSCRIBE FOR, SHARES OF THE COMPANY TO ANY PERSON IN THE UNITED STATES. THE SHARES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER U.S. SECURITIES ACT OR WITH ANY SECURITIES REGULATORY AUTHORITY OF ANY STATE OR OTHER JURISDICTION IN THE UNITED STATES, AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES, OR TO OR FOR THE ACCOUNT OR BENEFIT OF A U.S. PERSON, EXCEPT PURSUANT TO AN APPLICABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS.
This Company Presentation is subject to Norwegian law, and any dispute arising in respect of this Company Presentation is subject to the exclusive jurisdiction of Norwegian courts with Oslo District Court as first venue.





Comments Share of biomass exposed to elevated temperatures decreasing

1: Pre-Q3 batches: These fish were in the grow-out systems during the elevated temperatures in Q3 2023, while the post-Q3 batches were not. Only including fish in grow-out tanks



1: Pre-Q3 batches: These fish were in the grow-out systems during the elevated temperatures in Q3 2023, while the post-Q3 batches were not. Only including fish in grow-out tanks 2: Average of opening and closing biomass

Average feed conversion ratios (FCRs)1 1.47 1.02 1.90 1.03 Pre-Q3 batches Post-Q3 batches bFCR eFCR Weight dist., kg2 ~1.9 ~2.3 ~0.6 ~2.3

1: Pre-Q3 batches in growout systems: These fish were in the grow-out systems during the elevated temperatures in Q3 2023, while the post-Q3 batches were not. Only including fish in grow-out tanks 2: As of March 31, 2024 Note: In general feed conversion ratios are lower for fish of smaller sizes






▪ Signed agreement to start sourcing ~30% of electricity consumption from solar energy from mid-2024
▪ Supported several community initiatives, organized visits to the farm by schools, university students, researchers, neighbors, government authorities and more
▪ American Heart Association "Heart Check-Certified", Parent Tested Parent Approved (PTPA) Seal of Approval
▪ 80% of finished products packed in compostable and recyclable shipping boxes
▪ 100% of by-products from fileting operation sold as pet food ingredients
▪ Maintained FIFO under 1, making Atlantic Sapphire a net marine protein producer


| (USD 1,000) | 31 DECEMBER 2023 |
31 DECEMBER 2022 |
|---|---|---|
| Revenue | 13,995 | 18.954 |
| Cost of goods sold | (67,141) | (75,890) |
| Fair value adjustment on biological assets | (14,095) | 95 |
| Salary and personnel costs | (4,051) | (6,294) |
| Selling, general, and administrative costs | (7,984) | (10,449) |
| Other income (expense), net | 1,927 | 25,542 |
| Impairment of non-current assets | (35,000) | |
| Depreciation and amortization | (13,839) | (14,217) |
| Operating loss (EBIT) | (126,188) | (62,259) |
| Finance income | 1,516 | 4,907 |
| Finance expense | (9,086) | (7,654) |
| Loss before income tax | (133,758) | (65,006) |
| Income tax | ||
| Net loss | (133,758) | (65,006) |
| Non-IFRS measures | ||
| Operating loss (EBIT) | (126,188) | (62,259) |
| Add back: depreciation and amortization | 13.839 | 14.217 |
| EBITDA | (112.349) | (48,042) |
| Add back: fair value adjustment on biological assets | 14.095 | (85) |
| Add back: impairment of non-current assets | 35,000 | |
| Less: insurance proceeds from Denmark fire | (25,322) | |
| FRITDA adjusted | (63 254) | 173 4591 |

| (USD 1,000) | NOTE | 2023 | 2022 |
|---|---|---|---|
| Assets | |||
| Non-current assets | |||
| Property, plant, and equipment, net | 9 | 275,599 | 303,122 |
| Right of use asset | 8 | 1,971 | 2,512 |
| Restricted deposits | 13,16 | 15,172 | |
| Security deposits | 1,353 | 1,167 | |
| Other investments | 13 | ర్ | e |
| Trade and other receivables (non-current) | 13,14 | 481 | 1,343 |
| Total non-current assets | 294,582 | 308,150 | |
| Current assets | |||
| Prepaid and other current assets | 2,213 | 393 | |
| Inventories, net | 15 | 5,139 | 4,368 |
| Biological assets | 5 | 16,218 | 18,690 |
| Trade and other receivables, net | 13,14 | 1,155 | 1,847 |
| Restricted cash | 13,16 | 415 | 420 |
| Cash | 13,16 | 22,536 | 23,683 |
| Total current assets | 47,676 | 49,401 | |
| Total assets | 342,258 | 357,551 | |
| Equity and liabilities | |||
| Total equity | 283,140 | 296,382 | |
| Non-current liabilities | |||
| Borrowings (non-current) | 13,19 | 37,603 | 28,287 |
| Lease liability (non-current) | 8 | 1,729 | 2,218 |
| Total non-current liabilities | 39,332 | 30,505 | |
| Current liabilities | |||
| Borrowings (current) | 13,19 | 5,000 | 18,550 |
| Lease liability (current) | 8 | 450 | 416 |
| Trade and other payables | 13 | 14,336 | 11,698 |
| Total current liabilities | 19,786 | 30,664 | |
| Total aquity and liabilition | 340 268 | 367 551 |
1 Approximately USD2.6m of the \$20m RCF facility is currently utilized as a Letter of Credit for equipment leasing
2 As amended and restated. All the Group's debt facilities were extended until October 2026 in March 2024. Undrawn term debt is available subject to certain incurrence tests related to harvest volume and EBITDA. Harvest volume = a minimum required annualized production level to be maintained for at least two months. EBITDA = (i) aggregate positive EBITDA over the last three months prior to drawdown and (ii) a minimum EBITDA level

| YEAR ENDED 31 DECEMBER 2023 (USD 1,000) |
DENMARK OPERATIONS |
US OPERATIONS |
OTHER AND ELIMINATIONS |
CONSOLIDATED |
|---|---|---|---|---|
| Revenue from sale of salmon | 13,995 | 13,995 | ||
| EBITDA | (12) | (111,651) | (686) | (112,349) |
| EBITDA, pre-fair value adjustment | (12) | (97,556) | (686) | (98,254) |
| EBITDA, adjusted* | (12) | (62,556) | (686) | (63,254) |
| Pre-tax income (loss) | (65) | (137,748) | 4.055 | (133,758) |
| Total assets | 1,246 | 329,292 | 11,720 | 342,258 |
| Total liabilities | 1,282 | 154,773 | (96,937) | 59,118 |
| Depreciation and amortization | 23 | 13.815 | 1 | 13.839 |
| Interest income | 4 | 743 | 769 | 1,516 |
| Interest expense | 34 | 13,025 | (3,973) | 9.086 |
| Capital expenditures | 21,399 | 21,399 | ||
| Cash flows from operating activities | (153) | (77,988) | 379 | (77,762) |
| Cash flows from investing activities | 4 | (34,252) | 767 | (33,481) |
| Cash flows from financing activities | 378 | 103.758 | 6.189 | 110,325 |
All Focus is on the US, Considering to Divest the Remaining Danish Assets

1: Atlantic Sapphire 'Bluehouse premium' is fresh, superior salmon on Revenue Back To Farm basis (excluding freight costs). Average price achievement does not include revenues from the sale of frozen inventory and certain by-products


Significant Economies Of Scale To Be Unlocked Once Phase 2 Is Operational

▪


Phase 2 under construction to more than double capacity

experts



Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.